These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 7535482

  • 1. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression.
    Hadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM.
    Transplantation; 1995 Mar 27; 59(6):851-9. PubMed ID: 7535482
    [Abstract] [Full Text] [Related]

  • 2. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
    Singh N, Wannstedt C, Keyes L, Wagener MM, Cacciarelli TV.
    Liver Transpl; 2005 Jun 27; 11(6):700-4. PubMed ID: 15915496
    [Abstract] [Full Text] [Related]

  • 3. Risk factors associated with cytomegalovirus infection in orthotopic liver transplant patients.
    Hoppe L, Marroni CA, Bressane R, Lago L, Schiavo FL, Cigerza GC, Brandão AB, Zanotelli ML, Cantisani GP.
    Transplant Proc; 2006 Jun 27; 38(6):1922-3. PubMed ID: 16908324
    [Abstract] [Full Text] [Related]

  • 4. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
    van Burik JA, Carter SL, Freifeld AG, High KP, Godder KT, Papanicolaou GA, Mendizabal AM, Wagner JE, Yanovich S, Kernan NA.
    Biol Blood Marrow Transplant; 2007 Dec 27; 13(12):1487-98. PubMed ID: 18022579
    [Abstract] [Full Text] [Related]

  • 5. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME, Snydman DR, Ruthazer R, Griffith J, Werner BG, Freeman R, Rohrer R.
    Clin Transplant; 1997 Oct 27; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [Abstract] [Full Text] [Related]

  • 6. Risk factors associated with cytomegalovirus-positive antigenemia in orthotopic liver transplant patients.
    Hoppe L, Bressane R, Lago LS, Schiavo FL, Marroni CA, Keiserman DR, Brandão AB, Júnior AM, Cassal AP, Zanotelli ML, Cantisani GP.
    Transplant Proc; 2004 May 27; 36(4):961-3. PubMed ID: 15194334
    [Abstract] [Full Text] [Related]

  • 7. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
    Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, Charlton MR.
    Liver Transpl; 2002 Apr 27; 8(4):362-9. PubMed ID: 11965581
    [Abstract] [Full Text] [Related]

  • 8. Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation.
    Slifkin M, Ruthazer R, Freeman R, Bloom J, Fitzmaurice S, Fairchild R, Angelis M, Cooper J, Barefoot L, Rohrer R, Snydman DR.
    Liver Transpl; 2005 Dec 27; 11(12):1597-602. PubMed ID: 16315314
    [Abstract] [Full Text] [Related]

  • 9. Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants.
    Singh N, Gayowski T, Wagener M, Yu VL.
    Transplantation; 1994 Oct 15; 58(7):774-8. PubMed ID: 7524204
    [Abstract] [Full Text] [Related]

  • 10. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ, Malaise J, Moreno A, Crespo M, Fernández-Cruz L, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May 15; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for invasive fungal infections complicating orthotopic liver transplantation.
    Collins LA, Samore MH, Roberts MS, Luzzati R, Jenkins RL, Lewis WD, Karchmer AW.
    J Infect Dis; 1994 Sep 15; 170(3):644-52. PubMed ID: 8077723
    [Abstract] [Full Text] [Related]

  • 12. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, de Hemptinne B, Moench C.
    Liver Transpl; 2005 Nov 15; 11(11):1395-402. PubMed ID: 16237691
    [Abstract] [Full Text] [Related]

  • 13. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M, Pellegrini C, Martinelli L, Goggi C, Gavazzi A, Campana C, Arbustini E, Grossi P, Regazzi M, Ippoliti G, Vigano M.
    J Heart Lung Transplant; 1997 Oct 15; 16(10):1001-10. PubMed ID: 9361242
    [Abstract] [Full Text] [Related]

  • 14. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus.
    Lee JT, Whitson BA, Kelly RF, D'Cunha J, Dunitz JM, Hertz MI, Shumway SJ.
    J Surg Res; 2013 Sep 15; 184(1):599-604. PubMed ID: 23566442
    [Abstract] [Full Text] [Related]

  • 15. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S, Kling N, Bechstein WO, Blumhardt G, Lohmann R, Lobeck H, Neuhaus P.
    Clin Transplant; 1995 Oct 15; 9(5):406-14. PubMed ID: 8541635
    [Abstract] [Full Text] [Related]

  • 16. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
    Farges O, Saliba F, Farhamant H, Samuel D, Bismuth A, Reynes M, Bismuth H.
    Hepatology; 1996 Feb 15; 23(2):240-8. PubMed ID: 8591847
    [Abstract] [Full Text] [Related]

  • 17. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
    Reischig T, Jindra P, Svecová M, Kormunda S, Opatrný K, Treska V.
    J Clin Virol; 2006 Jun 15; 36(2):146-51. PubMed ID: 16531113
    [Abstract] [Full Text] [Related]

  • 18. Posttransplantation dialysis-associated infections: morbidity and impact on outcome in liver transplant recipients.
    Singh N, Gayowski T, Wagener MM.
    Liver Transpl; 2001 Feb 15; 7(2):100-5. PubMed ID: 11172392
    [Abstract] [Full Text] [Related]

  • 19. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.
    Schowengerdt KO, Naftel DC, Seib PM, Pearce FB, Addonizio LJ, Kirklin JK, Morrow WR.
    J Heart Lung Transplant; 1997 Dec 15; 16(12):1207-16. PubMed ID: 9436132
    [Abstract] [Full Text] [Related]

  • 20. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.
    Platz KP, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P.
    Transplantation; 1994 Jul 27; 58(2):170-8. PubMed ID: 7518975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.